Annals of Oncology 14:1455-1459, 2003
© 2003 European Society for Medical Oncology
Editorial |
Continuing medical education: a must for every medical oncologist
European Society of Medical Oncology
| The first 150 words of the full text of this article appear below. |
Introduction
Medical oncology is a rapidly changing subspeciality of internal medicine. Evidence-based medicine has led to continuous progress in knowledge, skills and attitudes of cancer care, and these improvements should be implemented in daily clinical practice. To ensure optimal treatment and care for cancer patients, medical oncologists must participate in continuing medical education (CME) programs. The main objectives of CME are to improve the quality of patient care, set standards of clinical competence for practice and encourage the continuing scholarship required for professional excellence over a lifetime of service.
To guarantee the maintenance of levels of knowledge and skills, as well as the improvement in attitudes to cancer care, the European Society of Medical Oncology (ESMO) has taken several educational initiatives.
ESMO examination
Since 1989, the ESMO Examination in Medical Oncology has given access to the ESMO Certificate in Medical Oncology. The main objective of this certificate was to create a basis for
ESMO medical oncology re-certification approval (MORA)
ESMO educational tools
ESMO Congress and ESMO Summer Education Congress
ESMO courses
ESMO faculty list
Annals of Oncology and educational books
ESMO Minimum Clinical Recommendations
ESMO newsletter
ESMO technology transfer grant
ESMO fellowship
ESMO website
Difficulties and challenges
ESMO examination
ESMO-MORA
ESMO courses
Future strategy
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E Bajetta, A Gevorgyan, and H Mellstedt National integration of European standards Ann. Onc., June 1, 2007; 18(6): 969 - 970. [Full Text] [PDF] |
||||
![]() |
P. A. Kosmidis, H. Ludwig, and H. Mellstedt ESMO at 30: Mission ongoing Ann. Onc., September 1, 2005; 16(9): 1411 - 1412. [Full Text] [PDF] |
||||
![]() |
H. Ludwig A Foundation for the future Ann. Onc., January 1, 2005; 16(1): 3 - 3. [Full Text] [PDF] |
||||
